spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  targeted oncology 

 HSMN NewsFeed - 1 Nov 2021
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Sep 2021
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 May 2021
Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Dec 2020
Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Devices Oncology Venture Capital
 HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Biopharmaceuticals Licensing Acquisitions
 HSMN NewsFeed - 22 Jul 2020
Olema Oncology Announces $54 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Aug 2018
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jan 2018
BridgeBio Pharma Licenses Late-Stage Oncology Drug Infigratinib to Tackle FGFR-Driven Maladies; Establishes New Subsidiary QED Therapeutics with $65 Million in Initial Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Dec 2015
Kesios Therapeutics Raises £19 Million in Series A Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jul 2015
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 21 Aug 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Jul 2014
Ipsen submits marketing authorization applications in the US and Europe for Somatuline(R) (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2014
William R. Ringo Joins Mirati Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Sep 2013
Mirati Therapeutics Appoints Isan Chen as Chief Medical and Development Officer and Adds Craig Johnson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2013
William L. Ashton Joins Galena Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Dec 2012
Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 May 2012
Galena Biopharma Announces Expansion of Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2012
Galena Biopharma Initiates Patient Enrollment in NeuVax(TM) Phase 3 PRESENT Trial to Prevent Breast Cancer Recurrence
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2011
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Cephalon Announces Definitive Agreement to Acquire Gemin X
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2009
AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 May 2008
Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
AVEO Pharmaceuticals Appoints David Johnston as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Oct 2007
Onyx Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2007
OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Dec 2006
GlaxoSmithKline and Genmab Enter Global Agreement For HuMax-CD20
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2006
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to Discover and Develop Novel Oncology Compounds
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 May 2006
Astex Announces New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2006
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 6 Mar 2006
Nereus Pharmaceuticals Closes Second Tranche of $42.6 Million Financing
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
targeted oncology
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.